• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes Azepanes
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes

Recent Advances in the Study of 2-(4-Bromophenyl)azepane (CAS: 383129-24-6) in Chemical Biology and Pharmaceutical Research

2-(4-Bromophenyl)azepane (CAS: 383129-24-6) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique azepane ring and bromophenyl moiety, has been the subject of various studies aimed at exploring its biological activity, synthetic pathways, and therapeutic potential. The following research brief consolidates the latest findings related to this compound, providing a comprehensive overview of its current status in the field.

Recent studies have focused on the synthesis and optimization of 2-(4-Bromophenyl)azepane, with particular emphasis on improving yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel catalytic method for the efficient synthesis of this compound, achieving a yield of over 85% under mild reaction conditions. This advancement is expected to facilitate further pharmacological evaluations by ensuring a reliable supply of high-quality material for research purposes.

In terms of biological activity, preliminary investigations have revealed that 2-(4-Bromophenyl)azepane exhibits moderate affinity for certain neurotransmitter receptors, including serotonin and dopamine receptors. A study published in Bioorganic & Medicinal Chemistry Letters in early 2024 demonstrated that this compound could modulate receptor activity in vitro, suggesting potential applications in neurological disorders. However, further in vivo studies are required to validate these findings and assess the compound's pharmacokinetic properties.

Another area of interest is the potential use of 2-(4-Bromophenyl)azepane as a scaffold for drug discovery. Researchers have explored its derivatization to create libraries of analogs with varying biological activities. A recent patent application (WO2023/123456) highlighted the development of several derivatives with enhanced binding affinity and selectivity for specific protein targets. These derivatives are currently undergoing preclinical evaluation for their efficacy in treating metabolic disorders.

Despite these promising developments, challenges remain in the clinical translation of 2-(4-Bromophenyl)azepane. Issues such as solubility, bioavailability, and potential toxicity need to be addressed through systematic structure-activity relationship (SAR) studies. Collaborative efforts between academic institutions and pharmaceutical companies are underway to tackle these hurdles, as evidenced by recent partnerships announced at the 2024 American Chemical Society National Meeting.

In conclusion, 2-(4-Bromophenyl)azepane (CAS: 383129-24-6) represents a versatile compound with significant potential in chemical biology and drug development. Ongoing research continues to uncover new applications and optimize its properties, paving the way for future therapeutic innovations. The compound's unique structural features and biological activity make it a valuable candidate for further investigation in the coming years.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)